BIO-TRAMADOL/ACET TABLET
Nchi: Kanada
Lugha: Kiingereza
Chanzo: Health Canada
Tabia za bidhaa
(SPC)
07-06-2018
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE
Inapatikana kutoka:
BIOMED PHARMA
ATC kanuni:
N02AJ13
INN (Jina la Kimataifa):
TRAMADOL AND PARACETAMOL
Kipimo:
325MG; 37.5MG
Dawa fomu:
TABLET
Tungo:
ACETAMINOPHEN 325MG; TRAMADOL HYDROCHLORIDE 37.5MG
Njia ya uendeshaji:
ORAL
Vitengo katika mfuko:
30/60/100/500
Dawa ya aina:
Narcotic (CDSA I)
Eneo la matibabu:
OPIATE AGONISTS
Bidhaa muhtasari:
Active ingredient group (AIG) number: 0250601001; AHFS:
Idhini hali ya:
CANCELLED PRE MARKET
Idhini ya tarehe:
2021-09-10
Tabia za bidhaa
_Page 1 of 56 _
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
PR
BIO-TRAMADOL/ACET
Acetaminophen and Tramadol Hydrochloride Tablets, House Std.
37.5 mg Tramadol Hydrochloride/325 mg Acetaminophen
Centrally Acting Analgesic
Date of preparation
June 7, 2018
Biomed Pharma
1565 boul. Lionel-Boulet
Varennes, Quebec
J3X 1P7
Control# 215703
_Page 2 of 56 _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.............................................................................
3
SUMMARY PRODUCT INFORMATION
.............................................................................................
3
INDICATIONS AND CLINICAL USE
...................................................................................................
3
CONTRAINDICATIONS
........................................................................................................................
4
WARNINGS AND PRECAUTIONS
.......................................................................................................
5
ADVERSE REACTIONS
.......................................................................................................................
15
DRUG INTERACTIONS
.......................................................................................................................
20
DOSAGE AND ADMINISTRATION
...................................................................................................
23
OVERDOSAGE
......................................................................................................................................27
ACTION AND CLINICAL PHARMACOLOGY
..................................................................................
27
STORAGE AND STABILITY
...............................................................................................................
33
DOSAGE FORMS, COMPOSITION AND PACKAGING
.................................................................. 33
PART II: SCIENTIFIC INFORMATION
.............................................................
Soma hati kamili
